This compound is a silyl-protected steroid derivative used as a pharmaceutical intermediate in the synthesis of steroid-based active pharmaceutical ingredients. Its structure includes both tert-butyldimethylsilyl and trimethylsilyl protecting groups, which facilitate selective chemical transformations during steroid backbone construction.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 91097-40-4
(17beta)-3-Oxoestra-4,6-dien-17-yl acetate
Pharmaceutical intermediate for steroid synthesis
(8S,13S,14S,17R)-13-Methyl-17-(2-methyl-1,3-dioxolan-2-yl)-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydrospiro(cyclopenta(a)phenanthrene-3,2'-(1,3)dioxolan)-17-ol
Pharmaceutical intermediate for steroid synthesis
Cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dione
Pharmaceutical intermediate for steroid synthesis
Androsta-4,8-diene-3,17-dione
Pharmaceutical intermediate for steroid synthesis
5-bromo-2-methyl-3-nitropyridine
pharmaceutical intermediate
Benzhydryl (6R,7R)-3-(chloromethyl)-7-[(4-methylbenzoyl)amino]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
beta-lactam antibiotic intermediate
(1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylic acid
Pharmaceutical intermediate
3-aminoazetidine, 3-boc protected
pharmaceutical intermediate
methyl (4R)-4-[(3R,5S,8S,9S,10S,13R,14S,17R)-3-[tert-butyl(dimethyl)silyl]oxy-10,13-dimethyl-7-trimethylsilyloxy-2,3,4,5,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate
LLDQVINTBNWOHR-VNCOJPLFSA-N
C[C@H](CCC(=O)OC)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C(=C[C@H]4[C@@]3(CC[C@H](C4)O[Si](C)(C)C(C)(C)C)C)O[Si](C)(C)C)C
—